Collective antibiotic tolerance: Mechanisms, dynamics and intervention

Nature Chemical Biology

Volumn 11, Issue 3, 2015, Pages 182-188

  Meredith, Hannah R ^a   Srimani, Jaydeep K ^a   Lee, Anna J ^a   Lopatkin, Allison J ^a   You, Lingchong ^a,b  

^a Duke University   (United States)

^b DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; BACTERIAL PHENOMENA AND FUNCTIONS; BACTERIAL SURVIVAL; COLLECTIVE ANTIBIOTIC TOLERANCE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG MECHANISM; DRUG TOLERANCE; DYNAMICS; HUMAN; INTERVENTION STUDY; MICROBIAL DIVERSITY; NONHUMAN; PRIORITY JOURNAL; QUORUM SENSING; REVIEW; SHELF LIFE; TIME TO TREATMENT; ANIMAL; BACTERIA; BACTERIAL INFECTIONS; DRUG EFFECTS; MICROBIOLOGY; PHYSIOLOGY;

BACTERIA (MICROORGANISMS);

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; DRUG RESISTANCE, BACTERIAL; HUMANS;

EID: 84923353801     PISSN: 15524450     EISSN: 15524469     Source Type: Journal    
DOI: 10.1038/nchembio.1754     Document Type: Review

References (93)

1. Levy, S.B. & Marshall, B. Antibacterial resistance worldwide: causes, challenges and responses. Nat. Med. 10, S122-S129 (2004).
2. Projan, S.J. Why is big Pharma getting out of antibacterial drug discovery? Curr. Opin. Microbiol. 6, 427-430 (2003).
3. Fishman, N. Antimicrobial stewardship. Am. J. Infect. Control 34, S55-S63 (2006).
4. Davies, J. & Davies, D. Origins and evolution of antibiotic resistance. Microbiol. Mol. Biol. Rev. 74, 417-433 (2010).
5. Tuomanen, E., Durack, D. & Tomasz, A. Antibiotic tolerance among clinical isolates of bacteria. Antimicrob. Agents Chemother. 30, 521-527 (1986).
6. Lewis, K. Persister cells, dormancy and infectious disease. Nat. Rev. Microbiol. 5, 48-56 (2007).
7. Johnson, P.J. & Levin, B.R. Pharmacodynamics, population dynamics, and the evolution of persistence in Staphylococcus aureus. PLoS Genet. 9, e1003123 (2013).
8. Levin, B.R. & Rozen, D.E. Non-inherited antibiotic resistance. Nat. Rev. Microbiol. 4, 556-562 (2006).
9. Balaban, N.Q., Merrin, J., Chait, R., Kowalik, L. & Leibler, S. Bacterial persistence as a phenotypic switch. Science 305, 1622-1625 (2004).
10. Tan, C. et al. The inoculum effect and band-pass bacterial response to periodic antibiotic treatment. Mol. Syst. Biol. 8, 617 (2012).
11. Lee, J.H. & Lee, J. Indole as an intercellular signal in microbial communities. FEMS Microbiol. Rev. 34, 426-444 (2010).
12. Hu, B., Du, J., Zou, R.-y. & Yuan, Y.-j. An environment-sensitive synthetic microbial ecosystem. PLoS ONE 5, e10619 (2010).
13. Tanouchi, Y., Lee, A.J., Meredith, H. & You, L. Programmed cell death in bacteria and implications for antibiotic therapy. Trends Microbiol. 21, 265-270 (2013).
14. Nedelcu, A.M., Driscoll, W.W., Durand, P.M., Herron, M.D. & Rashidi, A. On the paradigm of altruistic suicide in the unicellular world. Evolution 65, 3-20 (2011).
15. Thomson, K.S. & Moland, E.S. Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum β-lactamase-producing Enterobacteriaceae. Antimicrob. Agents Chemother. 45, 3548-3554 (2001).
16. Sykes, R.B. & Matthew, M. The β-lactamases of gram-negative bacteria and their role in resistance to β-lactam antibiotics. J. Antimicrob. Chemother. 2, 115-157 (1976).
17. Kolodkin-Gal, I., Sat, B., Keshet, A. & Engelberg-Kulka, H. The communication factor EDF and the toxin-antitoxin module mazEF determine the mode of action of antibiotics. PLoS Biol. 6, e319 (2008).
18. Engelberg-Kulka, H., Sat, B., Reches, M., Amitai, S. & Hazan, R. Bacterial programmed cell death systems as targets for antibiotics. Trends Microbiol. 12, 66-71 (2004).
19. McGannon, C.M., Fuller, C.A. & Weiss, A.A. Different classes of antibiotics differentially influence Shiga toxin production. Antimicrob. Agents Chemother. 54, 3790-3798 (2010).
20. Plunkett, G., Rose, D.J., Durfee, T.J. & Blattner, F.R. Sequence of Shiga toxin 2 phage 933W from Escherichia coli O157: H7: Shiga toxin as a phage late-gene product. J. Bacteriol. 181, 1767-1778 (1999).
21. Lainhart, W., Stolfa, G. & Koudelka, G.B. Shiga toxin as a bacterial defense against a eukaryotic predator, Tetrahymena thermophila. J. Bacteriol. 191, 5116-5122 (2009).
22. Miller, M.B. & Bassler, B.L. Quorum sensing in bacteria. Annu. Rev. Microbiol. 55, 165-199 (2001).
23. Hammer, B.K. & Bassler, B.L. Quorum sensing controls biofilm formation in Vibrio cholerae. Mol. Microbiol. 50, 101-104 (2003).
24. Pai, A., Tanouchi, Y. & You, L. Optimality and robustness in quorum sensing (QS)-mediated regulation of a costly public good enzyme. Proc. Natl. Acad. Sci. USA 109, 19810-19815 (2012).
25. Robicsek, A. et al. Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nat. Med. 12, 83-88 (2006).
26. Ding, X., Baca-DeLancey, R.R. & Rather, P.N. Role of SspA in the density-dependent expression of the transcriptional activator AarP in Providencia stuartii. FEMS Microbiol. Lett. 196, 25-29 (2001).
27. Juhas, M., Eberl, L. & Tümmler, B. Quorum sensing: the power of cooperation in the world of Pseudomonas. Environ. Microbiol. 7, 459-471 (2005).
28. Davies, D.G. et al. The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science 280, 295-298 (1998).
29. Ishida, H. et al. In vitro and in vivo activities of levofloxacin against biofilm-producing Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 42, 1641-1645 (1998).
30. Singh, R., Ray, P., Das, A. & Sharma, M. Penetration of antibiotics through Staphylococcus aureus and Staphylococcus epidermidis biofilms. J. Antimicrob. Chemother. 65, 1955-1958 (2010).
31. Anderl, J.N., Franklin, M.J. & Stewart, P.S. Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob. Agents Chemother. 44, 1818-1824 (2000).
32. Giwercman, B., Jensen, E., Høiby, N., Kharazmi, A. & Costerton, J. Induction of beta-lactamase production in Pseudomonas aeruginosa biofilm. Antimicrob. Agents Chemother. 35, 1008-1010 (1991).
33. Costerton, J.W., Stewart, P.S. & Greenberg, E. Bacterial biofilms: a common cause of persistent infections. Science 284, 1318-1322 (1999).
34. Craig, W.A., Bhavnani, S.M. & Ambrose, P.G. The inoculum effect: fact or artifact? Diagn. Microbiol. Infect. Dis. 50, 229-230 (2004).
35. Udekwu, K.I., Parrish, N., Ankomah, P., Baquero, F. & Levin, B.R. Functional relationship between bacterial cell density and the efficacy of antibiotics. J. Antimicrob. Chemother. 63, 745-757 (2009).
36. Tadmor, A.D. & Tlusty, T. A coarse-grained biophysical model of E. coli and its application to perturbation of the rRNA operon copy number. PLoS Comput. Biol. 4, e1000038 (2008).
37. Thron, C. Bistable biochemical switching and the control of the events of the cell cycle. Oncogene 15, 317-325 (1997).
38. VanBogelen, R.A. & Neidhardt, F.C. Ribosomes as sensors of heat and cold shock in Escherichia coli. Proc. Natl. Acad. Sci. USA 87, 5589-5593 (1990).
39. Sykes, M.T., Shajani, Z., Sperling, E., Beck, A.H. & Williamson, J.R. Quantitative proteomic analysis of ribosome assembly and turnover in vivo. J. Mol. Biol. 403, 331-345 (2010).
40. Rice, K.C. et al. The Staphylococcus aureus cidAB operon: evaluation of its role in regulation of murein hydrolase activity and penicillin tolerance. J. Bacteriol. 185, 2635-2643 (2003).
41. Rice, K.C. et al. The cidA murein hydrolase regulator contributes to DNA release and biofilm development in Staphylococcus aureus. Proc. Natl. Acad. Sci. USA 104, 8113-8118 (2007).
42. Bayles, K.W. The biological role of death and lysis in biofilm development. Nat. Rev. Microbiol. 5, 721-726 (2007).
43. Groicher, K.H., Firek, B.A., Fujimoto, D.F. & Bayles, K.W. The Staphylococcus aureus lrgAB operon modulates murein hydrolase activity and penicillin tolerance. J. Bacteriol. 182, 1794-1801 (2000).
44. Köhler, T., Curty, L.K., Barja, F., van Delden, C. & Pechère, J.-C. Swarming of Pseudomonas aeruginosa is dependent on cell-to-cell signaling and requires flagella and pili. J. Bacteriol. 182, 5990-5996 (2000).
45. Butler, M.T., Wang, Q. & Harshey, R.M. Cell density and mobility protect swarming bacteria against antibiotics. Proc. Natl. Acad. Sci. USA 107, 3776-3781 (2010).
46. Kim, W., Killam, T., Sood, V. & Surette, M.G. Swarm-cell differentiation in Salmonella enterica serovar Typhimurium results in elevated resistance to multiple antibiotics. J. Bacteriol. 185, 3111-3117 (2003).
47. Verstraeten, N. et al. Living on a surface: swarming and biofilm formation. Trends Microbiol. 16, 496-506 (2008).
48. van Ditmarsch, D. et al. Convergent evolution of hyperswarming leads to impaired biofilm formation in pathogenic bacteria. Cell Reports 4, 697-708 (2013).
49. Overhage, J., Bains, M., Brazas, M.D. & Hancock, R.E. Swarming of Pseudomonas aeruginosa is a complex adaptation leading to increased production of virulence factors and antibiotic resistance. J. Bacteriol. 190, 2671-2679 (2008).
50. Gunn, J.S. Bacterial modification of LPS and resistance to antimicrobial peptides. J. Endotoxin Res. 7, 57-62 (2001).
51. Lee, H.H., Molla, M.N., Cantor, C.R. & Collins, J.J. Bacterial charity work leads to population-wide resistance. Nature 467, 82-85 (2010).
52. Andersen, J.B. et al. gfp-based N-acyl homoserine-lactone sensor systems for detection of bacterial communication. Appl. Environ. Microbiol. 67, 575-585 (2001).
53. Moons, P., Michiels, C.W. & Aertsen, A. Bacterial interactions in biofilms. Crit. Rev. Microbiol. 35, 157-168 (2009).
54. Allison, D.G. & Matthews, M. Effect of polysaccharide interactions on antibiotic susceptibility of Pseudomonas aeruginosa. J. Appl. Bacteriol. 73, 484-488 (1992).
55. Kurioka, T., Yunou, Y., Harada, H. & Kita, E. Efficacy of antibiotic therapy for infection with Shiga-like toxin-producing Escherichia coli O157: H7 in mice with protein-calorie malnutrition. Eur. J. Clin. Microbiol. Infect. Dis. 18, 561-571 (1999).
56. Kumon, H., Ono, N., Iida, M. & Nickel, J.C. Combination effect of fosfomycin and ofloxacin against Pseudomonas aeruginosa growing in a biofilm. Antimicrob. Agents Chemother. 39, 1038-1044 (1995).
57. Wolcott, R.D. et al. Biofilm maturity studies indicate sharp debridement opens a time-dependent therapeutic window. J. Wound Care 19, 320-328 (2010).
58. Jacoby, G.A. AmpC β-lactamases. Clin. Microbiol. Rev. 22, 161-182 (2009).
59. Drawz, S.M. & Bonomo, R.A. Three decades of β-lactamase inhibitors. Clin. Microbiol. Rev. 23, 160-201 (2010).
60. Chaïbi, E.B., Sirot, D., Paul, G. & Labia, R. Inhibitor-resistant TEM β-lactamases: phenotypic, genetic and biochemical characteristics. J. Antimicrob. Chemother. 43, 447-458 (1999).
61. Mutschler, H. & Meinhart, A. e/ systems: their role in resistance, virulence, and their potential for antibiotic development. J. Mol. Med. 89, 1183-1194 (2011).
62. Lioy, V.S., Rey, O., Balsa, D., Pellicer, T. & Alonso, J.C. A toxin-antitoxin module as a target for antimicrobial development. Plasmid 63, 31-39 (2010).
63. Berry, A.M., Lock, R.A., Hansman, D. & Paton, J.C. Contribution of autolysin to virulence of Streptococcus pneumoniae. Infect. Immun. 57, 2324-2330 (1989).
64. Tanouchi, Y., Pai, A., Buchler, N.E. & You, L. Programming stress-induced altruistic death in engineered bacteria. Mol. Syst. Biol. 8, 626 (2012).
65. Tateda, K. et al. Azithromycin inhibits quorum sensing in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 45, 1930-1933 (2001).
66. van Delden, C. et al. Azithromycin to prevent Pseudomonas aeruginosa ventilator-associated pneumonia by inhibition of quorum sensing: a randomized controlled trial. Intensive Care Med. 38, 1118-1125 (2012).
67. Dong, Y.-H., Xu, J.-L., Li, X.-Z. & Zhang, L.-H. AiiA, an enzyme that inactivates the acylhomoserine lactone quorum-sensing signal and attenuates the virulence of Erwinia carotovora. Proc. Natl. Acad. Sci. USA 97, 3526-3531 (2000).
68. O'Loughlin, C.T. et al. A quorum-sensing inhibitor blocks Pseudomonas aeruginosa virulence and biofilm formation. Proc. Natl. Acad. Sci. USA 110, 17981-17986 (2013).
69. Brackman, G., Cos, P., Maes, L., Nelis, H.J. & Coenye, T. Quorum sensing inhibitors increase the susceptibility of bacterial biofilms to antibiotics in vitro and in vivo. Antimicrob. Agents Chemother. 55, 2655-2661 (2011).
70. Soong, G. et al. Bacterial neuraminidase facilitates mucosal infection by participating in biofilm production. J. Clin. Invest. 116, 2297-2305 (2006).
71. Mehta, R. & Champney, W.S. 30S ribosomal subunit assembly is a target for inhibition by aminoglycosides in Escherichia coli. Antimicrob. Agents Chemother. 46, 1546-1549 (2002).
72. Maisonneuve, E. & Gerdes, K. Molecular mechanisms underlying bacterial persisters. Cell 157, 539-548 (2014).
73. Dalebroux, Z.D., Svensson, S.L., Gaynor, E.C. & Swanson, M.S. ppGpp conjures bacterial virulence. Microbiol. Mol. Biol. Rev. 74, 171-199 (2010).
74. Kohanski, M.A., Dwyer, D.J., Hayete, B., Lawrence, C.A. & Collins, J.J. A common mechanism of cellular death induced by bactericidal antibiotics. Cell 130, 797-810 (2007).
75. Toguchi, A., Siano, M., Burkart, M. & Harshey, R.M. Genetics of swarming motility in Salmonella enterica serovar Typhimurium: critical role for lipopolysaccharide. J. Bacteriol. 182, 6308-6321 (2000).
76. Mireles, J.R., Toguchi, A. & Harshey, R.M. Salmonella enterica serovar typhimurium swarming mutants with altered biofilm-forming abilities: surfactin inhibits biofilm formation. J. Bacteriol. 183, 5848-5854 (2001).
77. Brook, I., Pazzaglia, G., Coolbaugh, J.C. & Walker, R.I. In-vivo protection of group A β-haemolytic streptococci from penicillin by β-lactamase-producing Bacteroides species. J. Antimicrob. Chemother. 12, 599-606 (1983).
78. Citorik, R.J., Mimee, M. & Lu, T.K. Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases. Nat. Biotechnol. 32, 1141-1145 (2014).
79. Bikard, D. et al. Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials. Nat. Biotechnol. 32, 1146-1150 (2014).
80. Eagle, H. & Musselman, A.D. The rate of bactericidal action of penicillin in vitro as a function of its concentration, and its paradoxically reduced activity at high concentrations against certain organisms. J. Exp. Med. 88, 99-131 (1948).
81. Hentzer, M. et al. Attenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors. EMBO J. 22, 3803-3815 (2003).
82. Hentzer, M. & Givskov, M. Pharmacological inhibition of quorum sensing for the treatment of chronic bacterial infections. J. Clin. Invest. 112, 1300-1307 (2003).
83. Köhler, T., Perron, G.G., Buckling, A. & Van Delden, C. Quorum sensing inhibition selects for virulence and cooperation in Pseudomonas aeruginosa. PLoS Pathog. 6, e1000883 (2010).
84. Nalca, Y. et al. Quorum-sensing antagonistic activities of azithromycin in Pseudomonas aeruginosa PAO1: a global approach. Antimicrob. Agents Chemother. 50, 1680-1688 (2006).
85. Schuster, M., Joseph Sexton, D., Diggle, S.P. & Peter Greenberg, E. Acyl-homoserine lactone quorum sensing: from evolution to application. Annu. Rev. Microbiol. 67, 43-63 (2013).
86. Sandoz, K.M., Mitzimberg, S.M. & Schuster, M. Social cheating in Pseudomonas aeruginosa quorum sensing. Proc. Natl. Acad. Sci. USA 104, 15876-15881 (2007).
87. André, J.B. & Godelle, B. Multicellular organization in bacteria as a target for drug therapy. Ecol. Lett. 8, 800-810 (2005).
88. Dandekar, A.A., Chugani, S. & Greenberg, E.P. Bacterial quorum sensing and metabolic incentives to cooperate. Science 338, 264-266 (2012).
89. Chuang, J.S., Rivoire, O. & Leibler, S. Simpson's paradox in a synthetic microbial system. Science 323, 272-275 (2009).
90. Tanouchi, Y., Smith, R.P. & You, L. Engineering microbial systems to explore ecological and evolutionary dynamics. Curr. Opin. Biotechnol. 23, 791-797 (2012).
91. Darch, S.E., West, S.A., Winzer, K. & Diggle, S.P. Density-dependent fitness benefits in quorum-sensing bacterial populations. Proc. Natl. Acad. Sci. USA 109, 8259-8263 (2012).
92. Yurtsev, E.A., Chao, H.X., Datta, M.S., Artemova, T. & Gore, J. Bacterial cheating drives the population dynamics of cooperative antibiotic resistance plasmids. Mol. Syst. Biol. 9, 300-308 (2013).
93. Allen, R.C., Popat, R., Diggle, S.P. & Brown, S.P. Targeting virulence: can we make evolution-proof drugs? Nat. Rev. Microbiol. 12, 300-308 (2014).